LAZ Options: Bearish Signal for Lazard Ltd (LAZ)?
AI-powered insights updated on 11/4/2025.
Trend Strength
Below 50-day Moving Average
R S I Momentum
Weakening RSI
Price Change (30-day)
Underperforming Industry Average
Full Analysis Breakdown
Lazard operates primarily in two business segments: Financial Advisory and Asset Management. The Financial Advisory business offers advice on 'mergers and acquisitions', 'capital markets', 'restructuring and liability management', and other strategic matters to corporations, governments, and individuals. This segment focuses on building long-term client relationships and providing senior-level attention during transaction execution. The Asset Management business provides global investment solutions in 'equity', 'fixed income', 'asset allocation', 'alternative investments', and 'private equity funds' to institutions and high-net-worth individuals. The company differentiates itself through its global reach, industry expertise, and a commitment to delivering superior investment performance and client service.
No relevant news was found for this stock today.
LAZ's technical outlook is bearish. The stock price has declined significantly over the past 90 days from approximately $57.75 in late August to $48.47 recently. The price is currently below the 21-day EMA of 49.78 and the 50-day SMA of 52.77, confirming the downtrend. The MACD is negative and trending downwards, with the MACD line (-1.02) below the signal line (-1.10), indicating bearish momentum. The RSI of 40.51 also suggests weakening strength, and the STOCHd is at 26.54, suggesting it is not yet oversold. The ADX at 38.45 indicates a strong trend, supporting the downtrend. BBP at 0.22 suggests the price is nearing the lower Bollinger Band, which could indicate a potential short-term bounce, but the overall trend remains downward, and a break below the lower band is possible. The ROC_20 is -4.35, which further supports the downward momentum. Given these indicators, LAZ is likely to continue its downward trajectory over the next 1-3 months.
Lazard's MD&A presents a mixed but slightly positive outlook. For the three months ended September 30, 2025, `Net Revenue` decreased by $37 million, or 5%, to $748.1 million, but `adjusted net revenue` increased $79 million, or 12%. The decrease in `Net revenue` was attributed to a $114 million gain on sale of an owned office building in the prior period. `Gross profit` margin is not explicitly stated, however, `Operating Income` decreased $66 million, or 41%, while `Adjusted operating income` increased $20 million, or 25%. For the nine months ended September 30, 2025, `Net cash provided by operating activities` was $120 million, a significant decrease from $380 million in the prior year. Management highlights that `annual results are the most meaningful basis for comparison`. The company continues to focus on 'the development of our business, including the generation of revenue growth, earnings growth and shareholder returns'. They also declared a quarterly dividend of $0.50 per share. While the decrease in cash from operations is a concern, the increase in `adjusted net revenue` and `adjusted operating income`, coupled with the dividend declaration, suggests a moderately stable outlook.
Lazard's Q2 2025 earnings call projects a moderately bullish outlook, driven by strong performance in Financial Advisory and positive momentum in Asset Management. Peter Orszag highlighted 'strong performance and results' with firm-wide adjusted net revenue of $1.4 billion for the first half. Financial Advisory achieved a record first half with adjusted net revenue of $861 million, showcasing geographic and product diversity. The company is seeing an 'increasingly constructive environment' for Financial Advisory activity, noting that corporate balance sheets are strong. Asset Management also showed progress with adjusted net revenue of $533 million for the first half, marked by positive net flows in the quarter and a 10% increase in AUM year-to-date. The company is also focusing on AI, which Peter Orszag believes will be 'transformational for both of our businesses'. While the comp ratio remained flat at 65.5%, management aims to reach their goal of 60% or below, depending on market conditions and hiring. Overall, the call conveys optimism about Lazard's growth trajectory, supported by diversification efforts and strategic investments.
LAZ's financial performance presents a somewhat neutral outlook. Revenue has fluctuated, starting at $774.01M in Q1 2024, peaking at $824.74M in Q4 2024, and then settling at $782.43M in the most recent quarter (Q3 2025), indicating some volatility but not a clear downward trend. Gross profit ratio has also seen fluctuations, beginning at a high of 0.95 in Q1 2024 (potentially an outlier due to data entry error), dropping to 0.34 in Q2 2024 before settling at 0.31 in Q3 2025. Operating cash flow has been inconsistent, with a significant negative value of -$89.99M in Q1 2024, improving to $362.85M in Q4 2024, and then declining to $33.49M in Q3 2023 before rising again to $49.68M in Q2 2025. The total debt has remained relatively stable, starting at $2.32B in Q1 2024 and ending at $2.20B in Q3 2025. Overall, while revenue and profitability have seen some fluctuations, the company's debt remains stable, and operating cash flow has improved recently, suggesting a somewhat stable financial position.
The company presents a moderately bullish investment profile based on its key metrics and financial ratios. Revenue has shown positive growth, indicating a healthy demand for its products or services. The gross margin has remained relatively stable, suggesting efficient cost management. The Return on Equity (ROE) indicates a solid return for shareholders. The Price-to-Earnings (P/E) ratio suggests the company is appropriately valued by the market. The debt-to-equity ratio has seen a decrease, showcasing the company's improved financial leverage. The current ratio signifies the company's strong ability to meet its short-term obligations. Overall, the company demonstrates a stable and growing business model with a healthy balance sheet, making it a moderately attractive investment for the next 6-12 months.
The information provided on this page is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the page's content as such. ProfitScout does not recommend that any security should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.